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USING SACCHAROMYCES CEREVISIAE TO STUDY THE ROLE OF THE X 
FAMILY DNA POLYMERASE POL4 IN CRISPR/CAS9-INDUCED MUTATION 
ABSTRACT 
The yeast repair DNA polymerase POL4 is part of the X family of DNA polymerases that 
function in DNA repair, specifically in gap filling for non-homologous end joining 
(NHEJ). POL4 is the only Pol X family polymerase in Saccharomyces cerevisiae and has 
been shown to have a role in creating deletions or insertions after double-strand break 
(DSB) repair by NHEJ, an error-prone mechanism. I investigated the role of the yeast 
POL4 genotype on mutations induced by a previously described yeast CRISPR/Cas9 
system. In this system a galactose-inducible Cas9 is used in combination with a gRNA 
targeted to the yeast CAN1 gene. CAN1 mutations are easily selected by resistance to 
canavanine. Our initial analysis suggested that the pol4 mutant genotype resulted in 
larger deletions compared to wild-type POL4. However, we found that the Cas9 plasmid 
induced mutations in the absence of galactose indicating that basal Cas9 expression was 
sufficient for inducing mutations. This suggested that the mutations I identified were in 
many cases clonal and not independent from each other. This hypothesis was supported 
by similar mutations being enriched for within an experiment performed on the same day. 
After controlling for independence, we did not detect a POL4 genotype-dependent effect 
on mutation type. We also asked whether the POL4 genotype affected the overall 
mutation frequency in both haploid and diploid yeast. We found pol4 haploids had less 
overall CRISPR/Cas9 induced mutations than POL4 haploids while in diploids the 
overall mutation frequency was lower than in haploids but did not vary by genotype. Our 
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results suggest that a requirement for POL4 in repair of DSBs caused by CRISPR/Cas9 is 
minor at best.  
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CHAPTER ONE: Introduction 
1.1 Thesis Summary 
 Targeted genome editing technologies have been sought for many decades and 
have important implications for genome editing and gene therapy. In recent years, the 
CRISPR/Cas9 system has risen to the forefront of these technologies and has produced 
promising results in many organisms. Herein I use a yeast CRISPR/Cas9 system to test 
the requirement for the yeast repair DNA polymerase POL4 for effective mutagenesis. 
Though we found slight differences between POL4 and pol4 strains, the pol4 mutation 
did not seem to affect the types of mutations induced by CRISPR/Cas9 and most likely 
has a small role in yeast DSB repair.   
1.2 Genome Engineering 	 Advances in biology over the past 30 years have allowed researchers to harness 
genome engineering technologies to edit or modify DNA sequences in living organisms. 
Earlier methods relied on homologous recombination and chemical recognition reagents 
to help introduce changes at DNA double-strand breaks (Doudna et al., 2014). Specific 
sequences were targeted for cleavage by base pair recognition using certain DNA 
damaging reagents, such as bleomycin (Doudna et al., 2014). However, these methods 
were inefficient, time-consuming and the reagents used introduced potential mutagenic 
effects (Gal et al., 2013). It was not until the early 2000s when genome engineering 
would experience its first breakthrough using zinc-finger nucleases (ZFNs) and later on, 
transcription activator-like effector nucleases, (TALENs).  
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1.2.1 ZFNs 
 ZFNs are highly specific endonucleases that are created by fusing a zinc-finger 
DNA-binding motif to the DNA cleavage domain of the Fok1 restriction endonuclease 
(Gasiunas et al., 2013). The DNA-binding domain (DBD) consists of three to six zinc 
finger repeats that can recognize 9-18 bp DNA sequences that confer high specificity in 
the genome (Gal et al., 2013). The Fok1 cleavage domain itself does not have sequence 
specificity and binds to a 5-7 spacer sequence adjacent to the recognition sequence (Gal 
et al., 2013). It requires dimerization to cleave and thus, two sets of ZFNs are needed. 
Once cleaved, the DSB will stimulate repair pathways, allowing for targeted gene 
deletions, integrations or other alterations (Gal et al., 2013). Despite its early potential for 
genome editing, ZFNs have several drawbacks. They are programmed for one DNA 
target and must be re-engineered at the protein level to use for other sites. Additionally, 
designing and optimizing the DBD is very time-consuming and expensive. Studies have 
also observed off-target sites and cell toxicity, which are major concerns due to the 
potential role of genome engineering in the medical field (Gupta et al., 2014).  
1.2.2 TALENs 
 TALENs are endonucleases that also are made by fusing the Fok1 cleavage 
domain with the TALE DBD. TALEs were discovered in the late 2000s and are naturally 
occurring proteins secreted by the plant pathogenic bacteria, Xanthomonas (Gupta et al., 
2014). The DBDs consist of repeated motifs ranging from 33-35 amino acids in length 
that each recognizes a specific base pair (Gasiunas et al., 2013). The fusion of the Fok1 
domain and TALE repeats allows for the complex to generate DSBs at target sites similar 
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to ZFNs. Generally, TALENs are advantageous to ZFNs in that they are time-efficient, 
easy to design and will bind to DNA sequences with high affinity (Gupta et al., 2014). 
While they may have advantages over ZFNs, off-target effects are still a major concern 
with TALENs (Gupta et al., 2014). Also, TALEN-expressing cDNAs are relatively large 
at approximately 3 kb, which might prove difficult to deliver and express in cells (Gupta 
et al., 2014).  
1.3 CRISPR 
 CRISPR (clustered regularly interspaced short palindromic repeats) are segments 
of short repetitive base sequences that have recently become key to developing accurate 
and efficient genome editing techniques, most commonly in the CRISPR/Cas9 system. 
The first studies on the CRISPR locus date back to 1993 but it took over a decade for 
scientists to realize its potential in genome editing across various model organisms. In the 
late 2000s, the potential for gene editing with CRISPR/Cas9 began to materialize when 
researchers discovered that sequences within CRISPR were transcribed into small RNAs 
called guide RNAs (gRNAs), that attach to target DNAs and help induce cleavage at a 
specific site (Brouns et al., 2008). From there, scientists harnessed this new technology 
and used the CRISPR/Cas9 system for genome editing in a variety of organisms. Its 
extensive potential was noticed worldwide in 2013 as noted by the dramatic increase of 
CRISPR publications on PubMed (1 in 2002, 283 in 2013 and 3041 in 2017.   
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1.3.1 Comparison to ZFNs and TALENs 
 Unlike ZFNs and TALENs, CRISPR-Cas9 can be easily reprogrammed to cleave 
any genomic sequence by modifying the sequence of the gRNA (Gaj et al., 2013). ZFNs 
and TALENs require designing protein complexes to target DNA which is more difficult 
and expensive than engineering gRNAs. The delivery process by which RNAs are 
introduced into model organisms is more efficient as it involves injection into embryos or 
the plasmid delivery whereas ZFNs and TALENs require transfection and selection (Gaj 
et al., 2013).  
1.3.2 Discovery 
What would later be called CRISPR repeats were first identified in Escherichia 
coli in 1987 (Ishino et al., 1987) The CRISPR locus was discovered and characterized in 
1993 by Francisco Mojica and through that decade, he identified repeat sequences that 
would become the hallmark of CRISPR sequences and eventually helped coin the term in 
2002 (Pourcel et al., 2005). In 2005, the endonuclease Cas9 and protospacer adjacent 
motif (PAM) were identified as key components in 2005 by Alexander Bolotin (Bolotin 
et al., 2005). At first, researchers proposed that the CRISPR system was involved in gene 
regulation, DNA repair and other processes (Lander, 2016). In 2003, Mojica utilized 
bioinformatics to compare extracted spacer sequences using the BLAST program and 
identified many sequences that matched viruses, prophages and conjugative plasmids 
(Lander, 2016). Around the same time, several other independent studies found similar 
findings (Richter et al., 2012). The hypothesis of adaptive immunity was proposed in 
2006 by Eugene Koonin and was shown experimentally in 2007 when phage DNA was 
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integrated into the CRISPR array in S.thermophilus, allowing for the bacteria to fend off 
phage infections (Barrangou et al., 2007). 
In order for the CRISPR array to arrive at target sequences, guide RNAs are 
required. The discovery of gRNAs in 2008 helped develop the model in which spacer 
sequences were transcribed into gRNAs which helped target Cas proteins to target 
sequences (Brouns et al, 2008). The basis of the CRISPR/Cas9 system was described in 
2010 and illustrates how Cas9 binds 3 nucleotides upstream of the PAM site and causes a 
double stranded break (Garneau et al, 2010). Finally, in 2013, this system was tested in 
eukaryotic cells when researchers designed CRISPR RNA or crRNA (part of the gRNA 
described below) for target genes in both human and mouse cells (Cong et al, 2013).  
1.3.3 Key Components 
 CRISPR-Cas9 is a simple system of genetic manipulation and only requires 
several components to be able to bind target DNA. The important molecules necessary 
are: 1) the Cas9 endonuclease, 2) the gRNA that is a hybrid of the tracrRNA and crRNA 
and 3) a target sequence with a PAM sequence.  
1.3.4 Cas9 
 Cas9 is a RNA-guided DNA endonuclease that naturally forms a complex with 
two small RNAs, crRNA and tracrRNA to induce cleavage at the target DNA site in the 
type II CRISPR system (Gasiunas et al., 2013). In bacteria, Cas9 is thought to have a 
strong role in adaptive immune defense against viruses, using short RNA to introduce 
double-stranded breaks in viral plasmids and phages, leading to degradation of foreign 
DNA (Mali et al., 2013). In the type II CRISPR system, Cas9 has a PAM sequence that 
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consists of NGG, with N indicating any nucleotide (Wang et al., 2016). Due to the low 
complexity of Cas9’s PAM requirement, it has become one of the most widely used Cas 
proteins for genomic editing (Wang et al., 2016).  
1.3.5 Cas9 Domains 
 Cas9 is comprised of six domains, HNH, RuvC, RECI, RECII, PI and BH 
(Sternberg et al., 2015). The two nuclease domains, HNH and RuvC, play a role in 
cleaving the target site recognized by the gRNA. The HNH domain cleaves the strand 
complementary to the guide RNA sequence and the RuvC domain cleaves the opposing 
nontarget strand (Wang et al., 2016). Both domains are required in order to generate a 
double-stranded break. Recent studies have used mutated nuclease domains to generate 
dCas9, which targets Cas9 to the binding site, but does not cleave the target DNA (Wang 
et al., 2016).  
1.3.6 Guide RNA  
 The small RNAs, crRNA and tracrRNA form the duplex gRNA that guides Cas9 
to the target site as long as the binding site consists of a matching 20-nucleotide 
protospacer sequence adjacent to the PAM sequence (Gasiunas et al., 2013). The 
tracrRNA initially has 25 bp of complementarity to the CRISPR repeats in the pre-
crRNA (Lander, 2016). It is essential for pre-crRNA processing into mature crRNA after 
transcription of the CRISPR-array (Richter et al., 2012). After tracrRNA hybridizes with 
pre-crRNA, the duplex is cleaved and further processed into a mature crRNA by 
RNaseIII (Richter et al., 2012). They bind and activate Cas9, allowing for DNA targeting 
and DNA cleavage. For genome engineering, gRNAs are a single RNA molecule 
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designed to incorporate the naturally occurring crRNA:tracrRNA duplex structure and 
can be programmed to target any DNA sequence with the correct PAM site, provided 
they have the matching nucleotide stretch (Gasiunas et al. 2013). 
1.3.7 Mechanism 
 The presence of gRNA is required to activate the Cas9 protein. Prior to gRNA 
binding, the Cas9 protein remains in an autoinhibited conformation in which the HNH 
domain is blocked by RuvC (Wang et al., 2016). The protein undergoes a conformational 
change and becomes active when bound to a gRNA (Wang et al., 2016). Once activated, 
Cas9 searches for the target DNA by binding to PAM sequences via the PAM Interacting 
domain, PI (Sternberg et al, 2015). When the protein binds a PAM sequence with an 
upstream region complementary with the gRNA sequence, the Cas9-gRNA complex will 
unwind and promote DNA strand separation (Sternberg et al, 2015). An R loop forms 
from the RNA-DNA heteroduplex, which causes a conformational change that activates 
the HNH and RuvC domains, inducing cleavage approximately 3 nucleotides upstream of 
the PAM sequence (Wang et al, 2016).  
1.4 Saccharomyces cerevisiae as a Model Organism 
 Saccharomyces cerevisiae is a widely used model organism and in 1996 was the 
first eukaryotic genome sequenced (Engel et al., 2014). Its genome contains about 6000 
genes spread over 12 million base pairs on 16 chromosomes (Duina et al., 2014). It has 
remained a very important model organism due to its contributions to the genetics, 
notably in cell cycle, metabolism, regulation of gene expression, signal transduction, and 
importantly recombination and DNA repair (Karathia et al., 2011).  
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 Saccharomyces cerevisiae’s popularity as a model organism stems from several 
factors. It is very cost-efficient to grow and maintain in the lab. It can survive under 
various environmental conditions, has very low nutritional needs, can be stored in -80˚C 
and can form colonies on agar plates in days (Duina et al., 2014). Yeast exists in both 
haploid and diploid states, and has two haploid mating types, a and a. Haploid a cells 
mate with haploid a cells to generate diploids and can then be induced to undergo 
meiosis to create new recombinant genotypes (Duina et al., 2014).  
1.5 Recent Studies on Yeast CAN1 Using CRISPR 
 Because of the efficiency of working with yeast and availability of isogenic 
mutations in every yeast gene for a variety of genetic backgrounds, using yeast to study 
how CRISPR functions can provide mechanistic insights more quickly than from work 
done in other systems. Recently, CRISPR/Cas9 was studied using the yeast CAN1 gene 
as a target for mutagenesis. CAN1 encodes a plasma membrane arginine permease in 
yeast (DiCarlo et al., 2013). Its inactivation leads to resistance to canavanine, a toxic 
arginine analog. Canavanine is transported into the cell in yeast expressing the CAN1 
gene. Thus, can1 mutants are easily selected based on canavanine resistance and this 
mutant selection scheme has been used previously to study mutation frequencies in many 
yeast studies. DiCarlo et al. (2013) harnessed the CRISPR/Cas9 system to target the 
CAN1 gene in Saccharomyces cerevisiae and observed strong Cas9 activity at the PAM 
site. Using a plasmid-borne gRNA expression cassette, DiCarlo et al. (2013) examined 
the CAN1 mutation frequencies of yeast expressing combinations of different CAN1 
gRNAs in combination with a galactose-inducible Cas9 gene. Results showed a 234-fold 
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increase in mutation frequency in the presence of Cas9 and the gRNA called CAN1.Y 
that was employed in my work (DiCarlo et al., 2013).   
1.6 DSB Repair Pathways 
1.6.1 Double-strand Breaks 
 CRISPR/Cas9 is used for targeted mutagenesis because it causes double-strand 
breaks (DSBs) that are repaired using error-prone mechanisms such as non-homologous 
end joining (NHEJ). In addition to DSBs induced by CRISPR/Cas9, DSBs in DNA occur 
for various reasons ranging from stress-induced to pathway-induced mechanisms. DSBs 
are critical to the cell’s viability and genome stability if not repaired (Shrivastav et al., 
2008). DSBs are not always repaired accurately (see below) and they can result in 
chromosomal aberrations such as deletions, insertions, translocations, and inversions 
(Shrivastav et al., 2008). DSBs can be repaired through several pathways, homologous 
recombination (HR), NHEJ and a recently discovered microhomology-mediated end 
joining (MMEJ) (McVey et al., 2008).  
1.6.2 Homologous Recombination 
 The HR repair pathway is often described as a more accurate mechanism than the 
NHEJ pathway due to the use of homologous sequences as a template for repair 
(Shrivastav et al., 2008). This process involves many Rad proteins, specifically Rad51, a 
DNA recombinase. End resection occurs when the proteins process the lesion, leaving 3’ 
overhanging tails. Strand invasion then occurs when the Rad51 protein searches for 
sequences similar to the 3’ overhang and moves it into the recipient DNA which acts as a 
template for repair, forming a displacement loop (D-loop) (Dudáš et al., 2004). DNA 
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polymerase then extends the end of the invading strand by synthesizing DNA. A Holliday 
junction forms and both damaged strands are repaired using the template from a 
homologous chromosome (Dudáš et al., 2004). The Holliday junctions are then cleaved 
by a resolvase, which could result in crossover or non-crossover depending on where the 
junction is cut (Dudáš et al., 2004). 
1.6.3 Non-homologous end joining  
 NHEJ is often characterized as the more error-prone repair pathway compared to 
HR, but it is still important in maintaining genome stability (Shrivastav et al., 2008). 
Unlike HR, it does not require a homologous template to initiate DNA repair (Davis et 
al., 2013). The DNA-end binding protein Ku binds the free ends at the DSB and acts as a 
scaffold to recruit DNA-dependent protein kinase catalytic subunit, DNA-PKcs, forming 
the active DNA-PK complex (Davis et al., 2013). After end-processing that can result in 
damaged bases being removed, DNA-PK is activated, and recruits XRCC4 and DNA 
ligase IV to seal the break (Khanna et al., 2001). DSBs with 5’ and 3’ overhangs are 
repaired by NHEJ with high fidelity, but many times small deletions result because of 
annealing of 1-4 base overhangs on each side of the break (Shrivastav et al., 2008).  
1.6.4 Microhomology-mediated end joining 
 MMEJ is a recently characterized repair mechanism that has received attention 
due to its error-prone mechanism and the generation of deletions, often leading to 
chromosome translocations (McVey et al., 2008). It is described as a subset of alternative 
end joining (A-NHEJ) and involves microhomologous sequences (5-25bp) on either side 
of the DSB to initiate repair (Wang et al., 2017). Recent studies have shown that MMEJ 
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is still used even when the HR repair pathway is available, suggesting that it could 
potentially be more than a back-up repair mechanism. (Troung et al., 2013). Similar to 
NHEJ, the first step of MMEJ is the initial end resection that exposes 3’ overhangs. If 
there are microhomologous sequences in the exposed 3’ overhangs, they can anneal and 
create 3’ tails adjacent to the annealed sequence. The 3’ tails are removed by a specific 
endonuclease, XPF/ERCC1, which allows DNA polymerase to synthesize, filling the gap 
(Wang et al., 2017). Finally, the repair process is completed by ligation by DNA ligase 
III/I (Wang et al., 2017). The result is deletion of the sequences in the microhomologous 
region. 
1.7.1 DNA Polymerase Family X 
 The X family of DNA polymerases includes Pol b, Pol l, Pol µ and terminal 
deoxynucleotidyl transferase (Yamtich et al., 2010). Unlike the polymerases involved in 
replication, the X family polymerases function in DNA repair and are mostly involved in 
gap filling (Daley et al., 2005). They are similar in sequence, but have different 
biochemical properties (Yamtich et al., 2010). Pol b functions in base excision repair 
(BER) whereas terminal deoxynucleotidyl transferase (Tdt) is involved in VDJ 
recombination in the B and T cell maturation. Both Pol l and Pol µ are associated with 
NHEJ (Yamtich et al, 2010). 
1.7.2 Yeast POL4  
 POL4 is the only Pol X family polymerase in Saccharomyces cerevisiae and is 
sometimes involved in gap filling for NHEJ (Daley et al., 2005). Since NHEJ is error-
prone, POL4-dependent repair could produce deletions or insertions after DSB repair. 
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Similar to other Pol X polymerases, it has been shown to not be required for all NHEJ 
events (Daley et al., 2005). Studies showed that Pol4 activation requires DSBs with 3’ 
overhangs and gaps on both strands (Daley et al., 2005).  
1.8 Statement of Thesis Rationale  
 The goal of my thesis was to test the role of yeast POL4 on CRISPR/Cas9-
induced mutations. I used two aims to study this question that both compared WT POL4 
yeast to pol4 mutant yeast. First I studied the effect of the pol4 mutant on the types of 
mutations (e.g. deletion or insertion). Second, I examined the effect of pol4 on overall 
mutation frequency in both haploid and diploid yeast strains. For theses analyses DSBs 
were generated at the PAM site of CAN1 gene, using CRISPR-Cas9 activation by 
galactose induction as described by DiCarlo et al. (2013). Due to pol4’s role in NHEJ, we 
hypothesized that a pol4 mutant would increase the possibility of errors during repair and 
possibly alter the size of deletion mutants. This analysis could provide insight into how 
important POL4 is for DSB repair in Saccharomyces cerevisiae and suggest approaches 
to altering the mutation landscape caused by CRISPR/Cas9. 
 Our initial findings suggested that pol4 did alter the deletion size, but upon further 
investigation I found that the CAS9 plasmid-induced mutations without galactose 
induction indicating that CAS9 was expressed at basal level as soon as it was transformed 
into the yeast cell. Thus, mutations that were assumed to be independent were instead 
likely clonal. After controlling for independence we detected no difference in mutation 
type. However, we did find a trend that pol4 haploids had less overall CRISPR/Cas9-
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induced mutants suggesting that POL4 has a minor role in repairing DSBs induced by 
CRISPR/Cas9. 
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Figure 1.1 Mechanism of CRISPR. (A) The CRISPR locus consists of the cas operon, 
which consists of cas9, cas1 cas2 and csn2. A CRISPR array of spacers from invader 
DNA sequences is located downstream. (B) The CRISPRs are transcribed into pre-
crRNAs. TracrRNA (~25bp stretch) binds crRNA and then the duplex binds Cas9, 
activating the endonuclease. Cas9 and RNase III are needed to process pre-crRNA into 
mature crRNA. (C) The RNA duplex along with Cas9 finds and binds the target DNA 
sequence. An R-loop is formed upstream of the PAM allowing the RuvC and HNH 
domains of Cas9 to cleave the site, generating a DSB.  
(Adapted from Doudna et al., 2014) 
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Figure 1.2 Cas9 Protein. Schematic showing the domains of the Cas9 protein (upper 
left). It consists of 6 domains, REC1, RECII, Bridge Helix, PAM Interacting, HNH and 
RuvC. The crystal structure is shown at the upper right and the primary structure is 
shown at the bottom of the figure. 
(Adapted from Cavanagh & Garrity, 2017) 
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Figure 1.3 Cas9 Model and yeast constructs. The model for how Cas9 complex targets 
specific genomic sequences (top) and constructs used in this work (middle and bottom). 
The Cas9 protein interacts with the guide RNA in order to target the PAM sequence 
(top). Cas9 was expressed from p415-GalL-Cas9-CYC1t (middle). The CAN1.Y 
genomic target ending with the PAM sequence, TGG, was expressed from p426-
SNR52p-gRNA.CAN1.Y-SUP4t.   
(Adapted from DiCarlo et al., 2013) 
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Figure 1.4. The yeast CAN1 coding sequence. Shown is the CAN1 coding sequence. 
The CAN1.Y gRNA sequence is in bold followed by the PAM in italics. Primers CAN1F 
(5’ to gRNA) and CAN1R (3’ to gRNA) are underlined and were used for PCR-
amplification of CAN1 from suspected canavanine-resistant mutants. Sequencing was 
done using CAN1F. 
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Figure 1.5 DSB repair pathways. Schematic showing the different repair pathways that 
could occur after a DSB. Generally, the two main repair pathways are HR and NHEJ. The 
additional pathways, SSA (not described herein) and MMEJ are more error-prone and are 
mutagenic.  
(Adapted from Jasin et al., 2013)  
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CHAPTER TWO: Materials and Methods 
2.1 Yeast Strains  	 The	wild type yeast strains, BY4741 (MATa his3D1 leu2D0 met15D0 ura3D0) and 
BY4742 (MATα his3D1 leu2D0 lys2D0 ura3D0) and isogenic pol4 mutant strains (MATa 
his3D1 leu2D0 lys2D0 ura3D0 pol4:KanMX) and MATα his3D1 leu2D0 met15D0 ura3D0 
pol4::KanMX were purchased from GE Healthcare Dharmacon and stored in a -80°C 
freezer. Yeast strains were revived by streaking on YPD plates and incubated at 30°C. 
MATα strains were used as the haploid strain. Diploid strains were created by mating the 
wild-type or pol4 strains to each other.   
2.2 Yeast Transformation 
Colonies were picked from plates and inoculated in 5 ml of YPD liquid medium 
and grown overnight at 30°C. For each culture, 0.5 ml of culture was transferred to a 1.5 
ml microcentrifuge tube. The yeast was then centrifuged for 10 seconds at full speed and 
the pellet was resuspended in 50 µl of sterile water by vigorous vortexing. For each 
transformation 10 µl of 10 mg/ml boiled herring sperm DNA was added in addition to 
1µg of p415-GalL-Cas9-CYC1t (p415) which encodes galactose-inducible Cas9 and 
p426-SNR52p-gRNA.CAN1.Y-SUP4t (p426) which encodes the guide RNA for 
targeting CAN1. After vortexing, 0.5 ml of freshly made transformation buffer consisting 
of 40% polyethylene glycol (PEG) 3350, 0.1 M lithium acetate, 10 mM Tris (pH 7.5), 1 
mM EDTA and 0.1M dithiothreitol (DTT) was added and vortexed thoroughly. The yeast 
cultures were left overnight at room temperature. The next day, the yeast cells were 
collected by centrifugation for 30 seconds in a microfuge at full speed. The cell pellet 
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was resuspended in 0.5 ml of sterile water. 300 µl of each sample was plated on SC-Leu-
Ura plates to select for both plasmids and incubated for 4-5 days at 30°C until colonies 
formed. 
2.3 Galactose induction and selection of canavanine-resistant mutants 
 Single colonies were picked from SC-Leu-Ura plates and inoculated in 5 ml of 
SC-Ura-Leu 2% glucose medium. Cultures were incubated at 30°C for two days. From 
these cultures, 1 ml of yeast was transferred to a 1.5 ml microfuge tube, centrifuged for 
30 seconds at full speed and resuspended in 1ml of sterile water after discarding the 
supernatant. This was repeated two additional times and then 200 µl of the yeast was 
inoculated in 5 ml of SC-Ura-Leu 2% galactose. Yeast cultures were left at 30°C for 3-4 
days. For canavanine-resistant mutant selection, 0.2 ml of undiluted galactose-induced 
culture was plated on SC-Arg + 60 µg/ml canavanine media. To determine the number of 
cells in each culture, cells were diluted 10,000 fold and 0.2 ml was plated on YPD. Plates 
were incubated at 30°C for 5 days to select for canavanine-resistant mutants. YPD plates 
were counted after two days growth at 30°C.  
2.4 Smash and Grab DNA Extraction 
Isolated canavanine-resistant colonies were picked and inoculated in 5 ml YPD 
liquid cultures. The “Smash and Grab” protocol was used to extract DNA of sufficient 
quality for PCR (Hoffman and Winston). Cultures were centrifuged at 10,000 rpm for 5 
minutes and the pellet was re-suspended in 0.5 ml of H2O and transferred to a screw cap 
1.5 ml microcentrifuge tube. Samples were centrifuged for 10 seconds at full speed and 
the supernatant was discarded after which the pellet was resuspended in residual 
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supernatant.  After 0.3 g of glass beads were added to each tube, 0.2 ml of “Smashing 
Buffer” (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA) 
and 0.2 ml of phenol:chloroform:isoamyl alcohol (25:24:1) was added. Each tube was 
vortexed vigorously at full speed for 3-4 minutes and then 200 µl of TE (10 mM Tris pH 
7.5, 1 mM EDTA) was added. Tubes were centrifuged for 5 minutes at 10,000 RPM. A 
micropipette was used to remove the top aqueous phase and then DNA was precipitated 
by the addition of 1.0 ml of 95% ethanol. Tubes were centrifuged for 2 minutes at full 
speed and the supernatant was discarded. Pellets were resuspended in 0.4 ml of TE 
buffer. Then, 3 µl of DNase-free RNase A was added, and tubes were incubated at room 
temperature for 20 minutes. Each PCR cocktail was prepared in 40 µl consisting of 1-10 
ng genomic DNA, 1X reaction buffer, 2 mM MgCl2, 200 µM dNTPs, 0.25 mM CAN1F 
primer, and 0.25 mM CAN1R primer. Two drops of mineral oil were added to the top of 
each tube and samples were incubated at 94°C for 5 minutes. The reaction was initiated 
by adding 2 units Taq polymerase in 10 µl of 1X reaction buffer and amplified using a 
program consisting of 40 cycles of 94°C (1 minute), 55°C (1 minute) and 72°C (3 
minutes). The primers used for amplification were CAN1F (5’-
CCGACATAGAGGAGAAGCATATGTA- 3’) and CAN1R (5’-
AGAGGATGTAACAGGGATGAATGT- 3’). These primers amplified a 434 bp 
fragment of the CAN1 gene surrounding the PAM adjacent to the CAN1.Y gRNA carried 
in plasmid p426. When the reaction finished, the program added a 10-minute incubation 
at 72°C followed by 4°C indefinitely.  
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2.5 PCR Product Purification  
PCR samples were transferred to microfuge tubes containing 250 µl of PB buffer 
from the QiaQuick kit (Hilden, Germany). Each reaction was then pipetted to a spin 
column and centrifuged for 60 seconds. Any flow-through was discarded and 0.5 ml of 
buffer PE was added to the column to wash the bound DNA. Columns were centrifuged 
for 60 seconds and flow-through discarded. This was repeated to remove residual buffer. 
Columns were transferred to new 1.5 ml microfuge tubes and 60 µl of sterile water was 
added. After centrifuging for 1 minute, samples were stored at -20°C and then prepped 
for sequencing. 5 µl of the PCR were checked by 1.5% agarose gel electrophoresis. The 
presence of a ~430 bp band indicated that the PCR was successful.  
2.6 Sequencing 
To prep samples for sequencing, 10 µl amplified DNA (~200 ng) was added to 
new 1.5 ml microcentrifuge tubes. Then, 1 µl of sterile water and 1 µl (15 pmol) of the 
CAN1F primer (5’- CCGACATAGAGGAGAAGCATATGTA- 3’) was added to each 
tube. Samples were then shipped to Eton Bioscience Incorporated in San Diego, 
California for sequencing. DNA sequences were viewed using 4peaks 
(https://nucleobytes.com/4peaks/index.html) and analyzed for mutations using 
Sequencher 5.1 Demo (www.genecodes.com).
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CHAPTER THREE: CAN1 mutagenesis results  
3.1 Potential pol4-dependent Mutation Bias in CRISPR/Cas9 induced mutation of 
CAN1 
To determine if the POL4 genotype influenced the type of mutations caused by 
CRISPR/Cas9, we sequenced can1 mutant alleles derived from galactose-induced POL4 
and pol4 haploid yeast carrying p415 and p426. We used a previously described galactose 
induction protocol for Cas9 expression as described in Methods (DiCarlo et al., 2013) 
and canavanine-resistant colonies were selected on SC-Arg+Can plates. Individual 
canavanine-resistant colonies were grown, the DNA was isolated, and the CAN1 allele 
was PCR-amplified and sequenced. Based on our sequence analysis, we initially thought 
that there was mutation bias for classes of can1 mutations based on the POL4 genotype. 
We found large deletions larger than 9 bp in 5/26 of our sequences derived from the pol4 
mutant when compared with 0/21 from POL4 (Table 3.3). Though this is only observed 
in a small sample of sequences with mutations, it would be logical to see more severe 
mutations in pol4 as the POL4 DNA polymerase has a role in NHEJ. We also frequently 
observed the same 7-bp deletion consisting of the PAM site and 4-bp upstream, 
AGGATGG, in 5/26 pol4 sequences and 4/21 POL4 sequences (Table 3.3).  
In addition to the 7-bp deletion, other types of mutations were found frequently in 
both strains. There were similar percentages of small deletions of 1 to 5 bp, 11/26 (42%) 
from pol4 and 8/21 (38%) from POL4 (Table 3.3). Two transversions (GàT) were 
observed in pol4 sequences (Table 3.2). There were also insertions of one or two adenine 
at 4 bp upstream of the PAM site. This was evident in 3/26 (12%) of the pol4 mutant 
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sequences and 8/21 (38%) of the POL4 sequences (Table 3.3). It is uncertain why 
adenine is the most common insertion in the sequences.  
3.2 Common Mutations were dependent on Date  
These data were derived from 23 original transformants, with any one 
transformant used to isolate a batch of 3-5 canavanine-resistant mutants after galactose 
induction of that transformant. While each batch was performed mostly under the same 
procedure, there were noticeable trends in the mutations within each batch of yeast. The 
most obvious trend in the sequences is that yeast from each transformation and Cas9 
induction tend to have similar mutations such as those observed in the pol4 sequences 
from June 10, 2015 and the POL4 sequences from July 30, 2015 (Table 3.2). Most of the 
pol4 sequences from June 10, 2015 shared a single G deletion.  There was a noticeable 
common GàT transversion from June 4, 2015. In the batch of pol4 sequences from July 
22, 2015, 3 sequences had large deletions (Table 3.2). This trend led us to question if 
there was background CRISPR/Cas9 activity before galactose induction, indicating the 
isolated canavanine-resistant mutants were clonal.  
3.3 Cas9 causes similar types of mutations in POL4 and pol4 yeast when 
independently isolated canavanine-resistant mutants were identified 
To determine if yeast CRISPR/Cas9 system was active before galactose 
induction, we performed the experiments without inoculating colonies in galactose 
medium. For these experiments, one canavanine-resistant mutant was sequenced per 
transformant to assure independence. After switching to using glucose-grown 
independent colonies, we found a similar diversity in types of mutations as before but 
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specific dates appeared less enriched for specific mutations. Nonetheless, similar 
mutations still appeared in experiments done on different dates. For example, a common 
“A” insertion was found in sequences (Table 3.2) from July 20, 2016 (pol4), and August 
24, 2016 (POL4). The previously seen 7-bp deletion, AGGATGG was found on July 20, 
2016 (both genotypes), September 16, 2016 (pol4) and October 5, 2016 (pol4).  
Our initial thoughts on mutation bias associated with large deletions and 
insertions went away after switching to independent colonies. Before the switch, there 
were 5 pol4 sequences with large deletions while there were 0 POL4 sequences with 
large deletions (Table 3.3). However, after switching to independent colonies without 
galactose induction, there were 2 POL4 and 2 pol4 sequences with large deletions. 
Similarly, there were 3 pol4 sequences and 8 POL4 sequences with insertions before the 
switch but 4 pol4 and 3 POL4 sequences with insertions after the switch. Though some of 
the numbers from the table seem to indicate differences in bias between picking colonies 
from the same canavanine plate and from independent plates, the differences are not 
significant. Nonetheless, because CRISPR/Cas9-induced mutations appear before 
galactose induction, it is logical to only select one mutant per transformant if one wanted 
to assure identification of independent mutations.  
3.4 POL4 Haploid Yeast cells have higher CRISPR/Cas9-induced mutation 
frequency   
To test if the POL4 genotype influences the frequency of CRISPR/Cas9-induced 
mutations at CAN1, we transformed haploid POL4 and pol4 yeast and then plated 
cultures derived from five independent transformants directly on canavanine plates 
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without galactose induction. The frequency of canavanine resistant mutants was 
determined by comparing number of resistant colonies to total colonies plated as 
determined by serial dilution and growth on YPD plates. As seen in Table 3.4, there was 
a trend that pol4 mutant haploid yeast had ~50% the number of canavanine resistant 
colonies compared to POL4 yeast. However, as seen in our data points, the mutation 
frequencies are quite variable within any one experiment, making these differences not 
statistically significant. In the October 2016, November 2016 and December 2016 
batches, the POL4 yeast had higher mutation frequencies than pol4 yeast, ranging from 
13% to 417% more (Table 3.4). These data are consistent with the model in which the 
pol4 mutant is less efficient in repairing DSBs caused by CRISPR/Cas9.  
3.5 Haploid yeasts have higher CRISPR/Cas9-induced mutation frequencies than 
diploid yeasts 
To investigate if similar results could be generated in diploid cells, the previous 
experiment was repeated with homozygous pol4 and homozygous POL4 diploid yeast. 
Haploid yeast from both pol4 and POL4 strains generally had more CRISPR/Cas9-
induced mutants than their diploid counterparts. This was evident in the December 2016 
experiment seen in Table 3.4. In the December dataset, haploid pol4 yeast had a 29% 
higher mutation frequency than diploid pol4 yeast. It was noted that diploid POL4 yeast 
had very poor growth in culture compared with diploid pol4 and its mutation frequencies 
were significantly lower. Why diploid POL4 exhibited poor colony growth and low 
mutation frequencies is uncertain.  
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Table 3.1 Number of CAN1 colonies sequenced sorted by date.  
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Before Switch to Independent Colonies 
 
pol4 Sequences 4.26.15 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGT_______________________GATGAAGATGAAGGAGAAGTACAG_042615_1_1 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_042615_2_1 
 
pol4 Sequences 6.4.15  
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAA_GATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGATGATGGCATAGGTGATGAACGATGAAGGAGAAGTACAG_060415_1_2 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGATGATGGCATAGGTGATGAACGATGAAGGAGAAGTACAG_060415_2_2 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_060415_7_7 
 
pol4 Sequences 6.10.15 
 
CCCGACGAGAGTAAATGGCGAGGATACGT  TCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTGATCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_10_1 (INS) 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_061015_2_2 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_061015_3_3 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_061015_4_4 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_061015_5_5 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_061015_6_6 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_061015_8_8 
 
POL4 Sequences 7.8.15  
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_070815_1_1 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_070815_3_3 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGA TGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGAGTGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_070815_2_2 
 
POL4 Sequences 7.22.15  
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072215_4_4 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072215_7_7 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_072215_3_3 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_072215_6_6 
 
pol4 Sequences 7.22.15  
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072215_18 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_072215_15 
CCCGACGAGAGTAAATGGCGAGG______________________CATAGGTGATGAAGATGAAGGAGAAGTACAG_072215_10 
CCCGACGAGAGTAAATGGCGAGGATACGT____________________GGTGATGAAGATGAAGGAGAAGTACAG_072215_9 
CCCGACGAGAGTAAATGGCGAGGATACGT_______________________GATGAAGATGAAGGAGAAGTACAG_072215_16 
 
pol4 Sequences 7.30.15 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_1 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_3 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_9 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_12 
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POL4 Sequences 7.30.15 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_9 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_11 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_18 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG___ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_10 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG___ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_15 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGAT_____AGGTGATGAAGATGAAGGAGAAGTACAG_073015_12 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGAT_____AGGTGATGAAGATGAAGGAGAAGTACAG_073015_13 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_17 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_073015_19 
 
pol4 Sequences 7.16.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ3 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ2 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ5 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ4 
CCCGACGAGAGTAAATGGCGAGGATA_______________________GGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ1 
 
POL4 Sequences 7.16.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ10 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ6 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ7 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA___TGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ8 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_071616_RZ9 
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After Switch to Independent Colonies 
pol4 Sequences 7.20.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA  GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAA GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P8 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAA GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P9 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAA GGATGGCATAGGTGATGAAAATGAAGGAGAAGTACAG_072016_P10 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P11 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P2 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P4 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P5 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG___ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P3 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATG____ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P12 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P1 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_P7 
 
POL4 Sequences 7.20.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_B8 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGGGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_B4 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_B7 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_B9 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_B10 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG___ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_B1 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG___ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_B2 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG___ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_B6 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_072016_B11 
 
pol4 Sequences 8.4.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTAT_________CATAGGTGATGAAGATGAAGGAGAAGTACAG_080416_RZ2 
 
POL4 Sequences 8.4.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG  AGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_080416_RZ6 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCT________________AGGTGATGAAGATGAAGGAGAAGTACAG_080416_RZ7 
 
POL4 Sequences 8.24.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA GGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_082416_RZ5 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA___TGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_082416_RZ6 
CCCGACGAGAGTAAATGGCGAGGATA____________________________TGAAGATGAAGGAGAAGTACAG_082416_RZ7 
 
 
pol4 Sequences from 9.16.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_091616_RZ02 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_091616_RZ01 
CCCGACGAGAGTAAATGGCGAGGATA______________________AGGTGATGAAGATGAAGGAGAAGTACAG_091616_RZ04 
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POL4 Sequences from 9.16.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_091616_RZ07 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_091616_RZ10 
 
 
pol4 Sequences from 10.5.16 
 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAGGATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_WT 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGAG_ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_100516_RZ07 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA__ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_100516_RZ08 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA__ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_100516_RZ09 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGA__ATGGCATAGGTGATGAAGATGAAGGAGAAGTACAG_100516_RZ02 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_100516_RZ03 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_100516_RZ05 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_100516_RZ06 
CCCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGG_______CATAGGTGATGAAGATGAAGGAGAAGTACAG_100516_RZ11 
 
Table 3.2 CAN1 sequences sorted by date and genotype. POL4 and pol4 were 
sequenced and aligned with WT CAN1 sequence. Sequences done before and after the 
switch to independent colonies are separated. Insertions and deletions are highlighted, 
and base substitutions are labeled red.  
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Type of Mutation Number of sequences 
before switch to 
Independent Transformants 
Number of sequences after 
switch to Independent 
Transformants  
genotype pol4 N (%) POL4 N (%) pol4 N (%) POL4 N (%) 
Large Deletions (9+ bp) 5 (19%) 0 (0%) 2 (9%) 2 (13%) 
AGGATGG (7-bp del) 5 (19%) 4 (19%) 7 (30%) 3 (19%) 
Base Substitutions 2 (8%) 0 (0%) 0 (0%) 1 (6%) 
Small Deletion (1-5 bp) 11 (42%) 8 (38%) 10 (43%) 7 (44%) 
Insertion (A or AA) 3 (12%) 8 (38%) 4 (17%) 3 (19%) 
 
Table 3.3 CAN1 mutation type distribution. The number of POL4 and pol4 sequences 
for each type of CAN1 mutation found before and after switching to independent 
transformants are shown here.  There was a total of 26 pol4 sequences and 21 POL4 
sequences before the switch to independent transformants. After the switch, the totals 
were 23 pol4 sequences and 16 POL4 sequences. Percentages (%) were determined by 
dividing by the respective totals.  
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October 28, 2016 
 
Yeast Strain Mutation Frequency (per 
10,000,000)  
Average 
pol4 Haploid 1 680.1 968 
pol4 Haploid 2 668.6 
pol4 Haploid 3 730.8 
pol4 Haploid 4 1678.6 
pol4 Haploid 5 1084.0 
POL4 Haploid 1 2941.4 5015 
POL4 Haploid 2 7459.5 
POL4 Haploid 3 2927.3 
POL4 Haploid 4 6733.3 
 
November 16, 2016 
 
Yeast Strain Mutation Frequency (per 
10,000,000) 
Average 
pol4 Haploid 1 4693.9 4026 
pol4 Haploid 2 4315.8 
pol4 Haploid 3 4200.0 
pol4 Haploid 4 4186.0 
pol4 Haploid 5 2732.1 
POL4 Haploid 1 3809.5 4558 
POL4 Haploid 2 4878.0 
POL4 Haploid 4 2057.7 
POL4 Haploid 5 7488.0 
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December 1, 2016 
 
Yeast Strain Mutation Frequency (per 
10,000,000) 
Average 
pol4 Haploid 1 435.9 586 
pol4 Haploid 2 551.7 
pol4 Haploid 3 425.8 
pol4 Haploid 4 610.7 
pol4 Haploid 5 907.1 
POL4 Haploid 1 7016.4 2077 
POL4 Haploid 2 1471.8 
POL4 Haploid 3 875.0 
POL4 Haploid 4 750.0 
POL4 Haploid 5 271.8 
pol4 Diploid 1 470.3 454 
pol4 Diploid 2 579.4 
pol4 Diploid 3 419.2 
pol4 Diploid 4 371.9 
pol4 Diploid 5 426.6 
POL4 Diploid 1 28.6 19 
POL4 Diploid 2 10.1 
POL4 Diploid 4 48.1 
POL4 Diploid 5 7.6 
Table 3.4 Mutation frequencies for pol4 and POL4. These values were adjusted for all 
dilutions performed on cultures. Colonies were counted on canavanine and YPD plates in 
order to determine mutation frequency. 
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CHAPTER FOUR: Concluding remarks and future directions  
4.1 Discussion 
 Because of the potential for genome editing and gene therapy, the CRISPR/Cas9 
system has received much attention as a breakthrough for science and medicine. Because 
mutagenesis using CRISPR/Cas9 relies on error-prone repair mechanisms such as NHEJ 
and MMEJ, we tested the role of yeast POL4 on CRISPR/Cas9-induced mutations. 
Because POL4 is the only Pol X family polymerase in Sacharomyces cereivisiae and has 
a role in gap filling for NHEJ, we expected an increase in severe mutations such as large 
deletions and insertions in the pol4 mutant. However, when we compared the different 
classes of mutations made between POL4 and pol4, we found POL4 had minimal effects 
on the types of mutations made. Most mutations were deletions of more than a base or a 
single “A” insertion three bases 5’ to the PAM. This is consistent with another 
CRISPR/Cas9 study in Arabidopsis and Tobacco where sequences showed a bias for 
deletions and insertions near the PAM site (Jiang et al., 2013). We also found a 
frequently occurring specific 7-bp deletion, AGGATGG, suggestive of being repaired by 
MMEJ using a 4 base repeat (underlined) as microhomology in this sequence that 
contains the PAM (bold), CTATGGAGGATGGCATA. These similar types of mutations 
in POL4 and pol4 could potentially be due to POL4 not being required for all NHEJ 
events (Daley et al., 2005).  
 The potential increase in very large deletions in the PAM region could be due to 
POL4’s role in NHEJ. Since NHEJ is already an error-prone method of DSB repair, 
having mutant pol4 could further increase deletions and insertions after DSB repair. A 
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specific deletion at the PAM sequence could indicate the inability of repair machinery to 
fill the gap or failure to use microhomology sequences as a template. This could also 
indicate that MMEJ has a smaller role in the repair mechanism after Cas9 cleavage as 
POL4 activity has been shown to be important for both MMEJ and NHEJ (McVey et al., 
2008). While these two mutation types appear slightly more often in pol4 sequences, it 
does not appear to be a significant change.  
 We also tested whether the frequency of CRISPR/Cas9-induced mutations was 
altered by the POL4 genotype. We found a trend towards a reduced frequency suggestive 
of DSBs being repaired less efficiently in the pol4 mutant. We interpret our results to 
mean that POL4’s role in repair of DSBs using this CRISPR/Cas9 gRNA combination is 
minor at best. However, we are confident that NHEJ is used in this system as mutations 
in MRE11, YKU80 and LIF1 (Symington et al., 2011) lost the ability to make 
CRISPR/Cas9-mediated mutations (data not shown).  
 For our experiments using the CRISPR/Cas9 system, we saw average frequencies 
of 2077 - 5015 x 10-7 mutations in WT yeast compared to 33 x 10-7 spontaneous 
canavanine resistance (data from 2017 BI513 class). This 63- to 152-fold increase, while 
less than the 234-fold increase observed in DiCarlo et al. 2013, is at a similar order of 
magnitude increase. While the average mutation frequencies varied between batches, 
there was a large increase in mutation frequency. We also noticed that there was great 
variability within each experiment. We hypothesize that this could be due to basal 
CRISPR/Cas9 activity causing certain cultures to have higher frequencies compared to 
others, as it is likely that mutations are being induced directly after transformation occurs.  
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 We were surprised to find that in the absence of galactose, the CRISPR/Cas9 
induced mutation frequency was comparable to what DiCarlo saw after galactose 
induction. That galactose induction was not required was also evident in our results from 
Table 3.3 as similar mutations were generated with and without galactose induction. 
DiCarlo did not use a “no galactose” control and instead used a “no plasmid” control with 
galactose induction. We hypothesized that low-level basal expression of CAS9 from the 
GAL-L promoter is enough to induce gRNA-mediated DSBs. While the GAL-L promoter 
is described as having no expression in the absence of galactose, we note that very low 
levels of activity are seen in the original paper describing the promoter (Mumberg et al., 
1994). These findings suggest that very little CAS9 is needed to create DSBs and may 
have implications for other CAS9 applications.  
4.2 Future directions  
 Recent papers have successfully used different inducible promoters in order to 
control the CRISPR/Cas system (Liu et al., 2015). In the future, we could also harness 
and adopt the use of these promoters to have better control of the CRISPR/Cas9 system. 
To further determine if there is basal Cas9 activity, we could plate transformants on SC-
Ura-Leu and SC-Arg + 60 µg/ml canavanine plates simultaneously and isolate colonies 
for sequencing from the canavanine plates in order to check for basal CRISPR/Cas9 
induced mutations.  
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